Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 22 clinical trials
Adenoid Cystic Carcinoma Erbitux and Particle Therapy

The ACCEPT (A(denoid) c(ystic) c(arcinoma), E(rbitux, and) p(article) t(herapy))-trial is a prospective, monocentric phase I/II feasibility trial evaluating toxicity and efficacy in the combined treatment of intensity-modulated radiation therapy (IMRT) and carbon ion (C12) boost with the epidermal growth factor receptor (EGFR) antibody cetuximab. The primary objective of the study …

  • 68 views
  • 08 Nov, 2020
Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma

no clinical study on epidermal growth factor receptor tyrosine kinase inhibitors has been systematically conducted in adenoid cystic carcinoma. We design this phase II study EGFR TKIs in

  • 3 views
  • 31 Jul, 2021
  • 1 location
  • 0 views
  • 25 Jan, 2021
  • 1 location
Study of Intratumoral CV8102 in cMEL cSCC hnSCC and ACC

cystic carcinoma. Patients will receive CV8102 as single agent or in combination with SoC anti-PD-1 therapy.

pembrolizumab
squamous cell carcinoma of the head and neck
malignant melanoma of skin
squamous cell carcinoma
melanoma skin
  • 136 views
  • 13 Aug, 2021
  • 60 locations
Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

This is a phase I/II, non randomized, open-label, dose escalation study to investigate the safety, tolerability and preliminary efficacy of CB-103.

blood transfusion
growth factor
liposarcoma
serum bilirubin level
small molecule
  • 281 views
  • 26 Jan, 2021
  • 12 locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

) Rare Tumors [To obtain permission to enroll in the NOC cohort, contact: S1609SC@swog.org] (closed to accrual 03/15/2019) Adenoid cystic carcinoma (closed

thyroxine
monoclonal antibodies
pd-l1
somatostatin
lung cancer
  • 6048 views
  • 16 Sep, 2021
  • 818 locations
Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation

. The present ACCO (Adenoid Cystic Carcinoma and Carbon ion Only irradiation) study, a prospective, open-label, phase II, single-arm, investigator-initiated study, will therefore investigate the sole

  • 0 views
  • 05 Sep, 2021
  • 1 location
Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck

This is a Phase II study of imatinib (Glivec) administered as a daily oral treatment in patients with recurrent/metastatic adenoid cystic carcinoma of the head and neck overexpressing KIT.

ct scan
neutrophil count
carcinoma
KIT
head and neck carcinoma
  • 53 views
  • 07 Nov, 2020
  • 1 location
Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

This phase II trial studies how well axitinib and avelumab work in treating patients with adenoid cystic carcinoma that has come back or spread to other places in the body. Axitinib may stop the

  • 2 views
  • 23 Jan, 2021
  • 1 location
Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers

The purpose of this study is to see if the study drugs, lenvatinib and pembrolizumab, are effective in treating advanced Adenoid Cystic Carcinoma (ACC) or other salivary gland cancers that have

ct scan
pembrolizumab
anticoagulants
cancer
measurable disease
  • 0 views
  • 21 May, 2021
  • 8 locations